Here are the latest quarterly results of TORRENT PHARMA. For more details, see the TORRENT PHARMA financial fact sheet and TORRENT PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 24,910 | 24,910 | 25,910 | 26,600 | 27,320 | 27,450 | 28,590 | 28,890 | |
Other income | Rs m | -100 | 90 | 340 | 260 | -330 | 310 | 240 | -160 | |
Turnover | Rs m | 24,810 | 25,000 | 26,250 | 26,860 | 26,990 | 27,760 | 28,830 | 28,730 | |
Expenses | Rs m | 17,670 | 17,640 | 18,000 | 18,350 | 18,630 | 18,620 | 19,550 | 19,500 | |
Gross profit | Rs m | 7,240 | 7,270 | 7,910 | 8,250 | 9,570 | 8,830 | 9,040 | 9,390 | |
Depreciation | Rs m | 1,930 | 1,960 | 1,910 | 2,010 | 2,130 | 2,030 | 1,970 | 1,980 | |
Interest | Rs m | 1,020 | 1,070 | 1,030 | 910 | 800 | 800 | 750 | 640 | |
Profit before tax | Rs m | 4,190 | 4,330 | 5,310 | 5,590 | 6,310 | 6,310 | 6,560 | 6,610 | |
Tax | Rs m | 1,270 | 1,460 | 1,530 | 1,730 | 1,880 | 1,820 | 1,990 | 2,080 | |
Profit after tax | Rs m | 2,920 | 2,870 | 3,780 | 3,860 | 4,430 | 4,490 | 4,570 | 4,530 | |
Gross profit margin | % | 29.1 | 29.2 | 30.5 | 31.0 | 35.0 | 32.2 | 31.6 | 32.5 | |
Effective tax rate | % | 30.3 | 33.7 | 28.8 | 30.9 | 29.8 | 28.8 | 30.3 | 31.5 | |
Net profit margin | % | 11.7 | 11.5 | 14.6 | 14.5 | 16.2 | 16.4 | 16.0 | 15.7 | |
Diluted EPS | Rs | 8.6 | 8.5 | 11.2 | 11.4 | 13.1 | 13.3 | 13.5 | 13.4 | |
Diluted EPS (TTM) | Rs | 24.8 | 36.8 | 37.5 | 39.7 | 44.1 | 48.9 | 51.3 | 53.2 | |
Subscriber Feature |
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.